Introduction
Transparent, functionalised PMMA microparticle
| Id | Mean Diameter | Surface Modifications | Packaging Volume |
| 105 10 002 |
2 µm | Low Aggregation | 4 mL / 5% |
| 105 10 005 |
5 µm | Low Aggregation | 4 mL / 5% |
| 105 10 009 |
9 µm | Low Aggregation | 4 mL / 5% |
| 105 10 012 |
12 µm | Low Aggregation | 4 mL / 5% |
| 105 10 016 |
16 µm | Low Aggregation | 4 mL / 5% |
| 105 10 020 |
20 µm | Low Aggregation | 4 mL / 5% |
| 105 11 002 |
2 µm | 3D-Carboxy AF | 4 mL / 5% |
| 105 11 005 |
5 µm | 3D-Carboxy AF | 4 mL / 5% |
| 105 11 009 |
9 µm | 3D-Carboxy AF | 4 mL / 5% |
| 105 11 012 |
12 µm | 3D-Carboxy AF | 4 mL / 5% |
| 105 11 016 |
16 µm | 3D-Carboxy AF | 4 mL / 5% |
| 105 11 016 |
16 µm | 3D-Carboxy AF | 4 mL / 5% |
| 105 11 016 |
16 µm | 3D-Carboxy AF | 4 mL / 5% |
| 105 11 016 |
16 µm | 3D-Carboxy AF | 4 mL / 5% |
| 105 11 016 |
16 µm | 3D-Carboxy AF | 4 mL / 5% |
| 105 11 016 |
16 µm | 3D-Carboxy AF | 4 mL / 5% |
| 105 11 016 |
16 µm | 3D-Carboxy AF | 4 mL / 5% |
| 105 11 020 |
20 µm | 3D-Carboxy AF | 4 mL / 5% |
| 105 21 002 |
2 µm | Streptavidin | 1.5 mL / 1% |
| 105 21 005 |
5 µm | Streptavidin | 1.5 mL / 1% |
| 105 21 009 |
9 µm | Streptavidin | 1.5 mL / 1% |
| 105 21 012 |
12 µm | Streptavidin | 1.5 mL / 1% |
| 105 21 016 |
16 µm | Streptavidin | 1.5 mL / 1% |
| 105 21 020 |
20 µm | Streptavidin | 1.5 mL / 1% |
| 105 22 002 |
2 µm | Neutravidin | 1.5 mL / 1% |
| 105 22 005 |
5 µm | Neutravidin | 1.5 mL / 1% |
| 105 22 009 |
9 µm | Neutravidin | 1.5 mL / 1% |
| 105 22 012 |
12 µm | Neutravidin | 1.5 mL / 1% |
| 105 22 016 |
16 µm | Neutravidin | 1.5 mL / 1% |
| 105 22 020 |
20 µm | Neutravidin | 1.5 mL / 1% |
| 105 24 002 |
2 µm | 3D-Alkyne | 1.5 mL / 1% |
| 105 24 005 |
5 µm | 3D-Alkyne | 1.5 mL / 1% |
| 105 24 009 |
9 µm | 3D-Alkyne | 1.5 mL / 1% |
| 105 24 012 |
12 µm | 3D-Alkyne | 1.5 mL / 1% |
| 105 24 016 |
16 µm | 3D-Alkyne | 1.5 mL / 1% |
| 105 24 020 |
20 µm | 3D-Alkyne | 1.5 mL / 1% |
| 105 27 002 |
2 µm | Oligonucleotide (customer specific) | 1.0 mL / 0.1% |
| 105 27 005 |
5 µm | Oligonucleotide (customer specific) | 1.0 mL / 0.1% |
| 105 27 009 |
9 µm | Oligonucleotide (customer specific) | 1.0 mL / 0.1% |
| 105 27 012 |
12 µm | Oligonucleotide (customer specific) | 1.0 mL / 0.1% |
| 105 27 016 |
16 µm | Oligonucleotide (customer specific) | 1.0 mL / 0.1% |
| 105 27 020 |
20 µm | Oligonucleotide (customer specific) | 1.0 mL / 0.1% |
| 105 28 002 |
2 µm | Protein A/G | 1.5 mL / 1% |
| 105 28 005 |
5 µm | Protein A/G | 1.5 mL / 1% |
| 105 28 009 |
9 µm | Protein A/G | 1.5 mL / 1% |
| 105 28 012 |
12 µm | Protein A/G | 1.5 mL / 1% |
| 105 28 016 |
16 µm | Protein A/G | 1.5 mL / 1% |
| 105 28 020 |
20 µm | Protein A/G | 1.5 mL / 1% |
| 105 29 002 |
2 µm | Peptide (customer specific) | 1.0 mL / 0.1% |
| 105 29 005 |
5 µm | Peptide (customer specific) | 1.0 mL / 0.1% |
| 105 29 009 |
9 µm | Peptide (customer specific) | 1.0 mL / 0.1% |
| 105 29 012 |
12 µm | Peptide (customer specific) | 1.0 mL / 0.1% |
| 105 29 016 |
16 µm | Peptide (customer specific) | 1.0 mL / 0.1% |
| 105 29 020 |
20 µm | Peptide (customer specific) | 1.0 mL / 0.1% |
| 108 35 002 |
2 µm | 3D-Azide | 1.5 mL / 1% |
| 108 35 005 |
5 µm | 3D-Azide | 1.5 mL / 1% |
| 108 35 009 |
9 µm | 3D-Azide | 1.5 mL / 1% |
| 108 35 012 |
12 µm | 3D-Azide | 1.5 mL / 1% |
| 108 35 016 |
16 µm | 3D-Azide | 1.5 mL / 1% |
| 108 35 020 |
20 µm | 3D-Azide | 1.5 mL / 1% |
| 108 36 002 |
2 µm | 3D-Aldehyde | 1.5 mL / 1% |
| 108 36 005 |
5 µm | 3D-Aldehyde | 1.5 mL / 1% |
| 108 36 009 |
9 µm | 3D-Aldehyde | 1.5 mL / 1% |
| 108 36 012 |
12 µm | 3D-Aldehyde | 1.5 mL / 1% |
| 108 36 016 |
16 µm | 3D-Aldehyde | 1.5 mL / 1% |
| 108 36 020 |
20 µm | 3D-Aldehyde | 1.5 mL / 1% |
